The same research group studied rat models of PAH with portal hypertension and cirrhosis and described an exacerbation of PH phenotype and pulmonary vascular remodeling upon administration of a BMP9 ligand trap, highlighting an apparent protective effect of endogenous BMP9 (213). The gene discussed is GDF2; the disease is portal hypertension.